Search results
Showing results for
The first patient has now been registered to the ATOM trial, a single-centre (Churchill Hospital, Oxford University Hospitals Trust) pre-operative window of opportunity study of the effects of atovaquone on hypoxia in non-small cell lung carcinoma (NSCLC).
Kadoorie Institute for Trauma, Emergency and Critical Care
The Kadoorie Institute designs and tests innovative treatments and care pathways that improve patient outcomes and deliver more efficient healthcare. By combining resources and expertise across Trauma, Emergency and Critical Care, the Institute accelerates this research.
OxKen
The Oxford Kennedy MB PhD (BM DPhil) Educational Training Program